Skip to content

Similar papers

Open access Sep 2026

Pharmacokinetic and bioequivalence evaluation of teneligliptin hydrobromide tablets following single-dose administration in healthy Chinese volunteers under fasting and fed conditions

By inhibiting dipeptidyl peptidase-4 (DPP-4), teneligliptin provides a therapeutic option for type 2 diabetes mellitus (T2DM) that is widely used in Asia. A generic product could lessen treatment costs, provided that its systemic availability is equivalent to that of the branded formulation. Such comparative informatio...

Zhao-Feng Guan, Ming-Qi Chen, Bi-Ying Wei et al. · 0 citations
Review Aug 2026

Exploring the Clinical Pharmacokinetics of Sitagliptin in Healthy and Diseased Populations: A Systematic Critical Review.

The available PK data on sitagliptin from published studies in healthy and diseased subjects are summarized and may be useful for developing physiologically based PK models and may provide additional information to support clinicians in optimizing sitagliptin dosing in patient populations.

Tahira Saleem, M. Rasool, Hamid Saeed et al. · 0 citations
Sep 2026

Ursodeoxycholic Acid Oral Pharmacokinetics and Plasma Bile Acid Profile Changes in a Population of Healthy Neonatal Foals.

Ursodeoxycholic acid (UDCA) is a secondary bile acid used in humans for the treatment of some cholestatic diseases. Interest in its potential use in equine patients with liver conditions has increased. Pharmacokinetic parameters in adult horses have recently been reported; however, they are not available for foals. The...

T. Burdette, B. Delvescovo, E. W. Bellin et al. · 0 citations
Open access Sep 2026

Pharmacokinetics of meloxicam following intramuscular, subcutaneous, and oral administration in white storks (Ciconia ciconia)

Meloxicam (MLX) is a preferential cyclooxygenase-2 inhibitor widely used in avian medicine as an anti-inflammatory agent. Despite marked interspecific variability in avian drug disposition, no pharmacokinetic data are available for MLX in the white stork ( Ciconia ciconia ). This study aimed to characterise a...

Y. Gunes, Ebuderda Gunay, N. Yılmaz et al. · 0 citations
Clinical trial Open access Sep 2026

Effect of Food on Balcinrenone/Dapagliflozin Pharmacokinetics and the Pharmacokinetics of Balcinrenone When Dosed with a P‐gp Inhibitor

Balcinrenone (AZD9977) is a novel selective non‐steroidal mineralocorticoid receptor antagonist with a distinct mode of action being developed as a fixed‐dose combination with the sodium–glucose cotransporter‐2 inhibitor dapagliflozin for the treatment of heart failure with impaired kidney function, and chronic kidney...

A. Eriksson, D. Karsanji, Amy H. Shi et al. · 0 citations
Review Oct 2026

A systematic review of the clinical pharmacokinetics of fluconazole in healthy and diseased populations.

INTRODUCTION Fluconazole is a triazole antifungal agent commonly used to treat both systemic and superficial fungal infections. This comprehensive review aims to collate all published pharmacokinetic (PK) data on fluconazole in healthy and diseased subjects. METHODS A systematic search of Google Scholar, PubMed, and...

Tahira Saleem, Khadija Ameen, M. Rasool et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.